MacroGenics, Inc.
MGNX
$4.62
-$0.24-4.94%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -49.61% | -43.40% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -49.61% | -43.40% | |||
| Cost of Revenue | 0.94% | -0.47% | |||
| Gross Profit | -729.11% | -110.03% | |||
| SG&A Expenses | 5.14% | -6.76% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.67% | -1.62% | |||
| Operating Income | -176.42% | -164.91% | |||
| Income Before Tax | -146.28% | -188.76% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -159.80% | -184.15% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -159.80% | -184.15% | |||
| EBIT | -176.42% | -164.91% | |||
| EBITDA | -205.54% | -150.88% | |||
| EPS Basic | -159.10% | -184.10% | |||
| Normalized Basic EPS | -145.56% | -188.70% | |||
| EPS Diluted | -159.10% | -184.10% | |||
| Normalized Diluted EPS | -145.56% | -188.80% | |||
| Average Basic Shares Outstanding | 0.26% | 0.08% | |||
| Average Diluted Shares Outstanding | 0.26% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||